Alan Secures €480 Million, Valuation Soars to €5.5 Billion
June 30, 2026, 3:37 pm
Location: Canada, Ontario, Toronto
Employees: 1001-5000
Founded date: 1989
French health tech innovator Alan completed a monumental €480 million Series G funding round. This landmark investment elevates the company's valuation to €5.5 billion. Global tech investor Prosus led the round, with key participation from Teachers’ Venture Growth, Index Ventures, and new investor Dara Holdings. Alan champion's "prevention insurance," an AI-native platform integrating comprehensive health coverage, proactive care navigation, and essential wellbeing services. This strategic infusion of capital is earmarked for aggressive international expansion across Europe and North America, significant acquisitions, and advanced investment in AI-driven healthcare services and product innovation. The funding solidifies Alan's market leadership and its ambition to redefine the global healthcare experience from reactive to proactive, leveraging technology for greater accessibility and effectiveness.
Alan, the Paris-based digital health powerhouse, has closed a substantial €480 million Series G funding round. This capital infusion propelled the company’s valuation to an impressive €5.5 billion. The announcement arrived in late June 2026, marking another significant milestone for the rapidly expanding French insurer.
Prosus, a global technology investment giant, spearheaded this latest funding effort. Prosus committed €400 million, a blend of primary capital and secondary share purchases. Existing investors Teachers’ Venture Growth (TVG) and Index Ventures also participated. Dara Holdings joined as a new investor. The transaction awaits final regulatory approvals.
This Series G round follows closely on the heels of another major funding event. Just months prior, Alan secured €100 million, then valued at €5 billion. The company has now accumulated over €1.2 billion in total funding since its inception. These successive investments underscore investor confidence in Alan's disruptive business model and future growth trajectory.
Founded in 2016, Alan initially emerged as a digital health insurer. It swiftly evolved into a pioneering "prevention insurance" company. This innovative model integrates traditional health coverage with proactive care navigation and comprehensive wellbeing services. Artificial intelligence powers much of its platform. This approach aims to shift healthcare focus from reactive treatment to early intervention and prevention.
Alan’s integrated platform offers a unique healthcare experience. It combines diverse services under a single, user-friendly interface. Members access health coverage, care guidance, mental and physical wellbeing resources. AI-driven assistance further streamlines the experience. This design simplifies healthcare journeys for its growing user base.
The company demonstrates robust financial performance. In the first quarter of 2026, Alan surpassed €800 million in annual recurring revenue (ARR). This represents a significant 53% year-over-year growth. Alan maintains profitability in France, its largest and most established market. This financial strength provides a solid foundation for its ambitious expansion plans.
Alan serves a vast and diverse clientele. Over 1.1 million members now rely on its services. This includes individuals, more than 37,000 businesses, self-employed professionals, and retirees. The platform's adaptability caters to various segments of the healthcare market.
The fresh capital directly supports Alan's aggressive growth strategy. A primary focus is international expansion. Alan currently operates in France, Spain, Belgium, and Canada. The company intends to deepen its presence in these existing markets. It also plans to explore new countries, extending its reach globally.
Acquisitions form another key component of the strategic plan. Alan will pursue targeted acquisitions to bolster its capabilities and market share. This inorganic growth strategy complements its organic expansion efforts. These moves will consolidate its position as a leading health tech innovator.
Significant investment in artificial intelligence remains paramount. Alan aims to further develop its AI-native healthcare platform. This includes enhancing existing AI features and introducing new ones. The goal is to provide even more personalized, proactive, and efficient healthcare solutions. Investment in broader healthcare services and product development also continues. This ensures a continuously evolving and comprehensive offering.
Alan's long-term vision is clear: to establish prevention-focused insurance as the global preferred healthcare model. This ambition drives its product innovation and market penetration strategies. The company employs over 850 people, a dedicated team working towards this transformative goal.
The partnership with Prosus is highly strategic. Prosus brings deep expertise in international expansion and consumer products. This collaboration will help Alan scale its consumer offerings. It will also facilitate entry into large international markets where Prosus already holds a strong presence. Access to Prosus’ Large Commerce Model further accelerates Alan's AI-led product development.
Alan also fits into Prosus’ broader consumer ecosystem strategy. Its healthcare offerings strengthen Prosus’ life assistant strategy. This synergy benefits both entities, creating a more integrated consumer experience across various sectors.
Future initiatives include the planned launch of Alan Campus in January 2027. This digital health insurance offering targets students aged 18 to 28. It represents a strategic move to capture a crucial demographic early. This initiative aligns with Alan's prevention-first philosophy, promoting health awareness among young adults.
The company ensures robust operational integrity. It is regulated by the French Prudential Supervision and Resolution Authority. This oversight provides credibility and trust in its services.
Alan continues to redefine healthcare. Its focus on prevention, AI integration, and user-centric design sets a new industry standard. The recent funding round validates its approach. It also provides the necessary resources to accelerate its global mission. Alan's journey reflects a broader industry shift towards more proactive, technologically advanced healthcare solutions.
Alan, the Paris-based digital health powerhouse, has closed a substantial €480 million Series G funding round. This capital infusion propelled the company’s valuation to an impressive €5.5 billion. The announcement arrived in late June 2026, marking another significant milestone for the rapidly expanding French insurer.
Prosus, a global technology investment giant, spearheaded this latest funding effort. Prosus committed €400 million, a blend of primary capital and secondary share purchases. Existing investors Teachers’ Venture Growth (TVG) and Index Ventures also participated. Dara Holdings joined as a new investor. The transaction awaits final regulatory approvals.
This Series G round follows closely on the heels of another major funding event. Just months prior, Alan secured €100 million, then valued at €5 billion. The company has now accumulated over €1.2 billion in total funding since its inception. These successive investments underscore investor confidence in Alan's disruptive business model and future growth trajectory.
Founded in 2016, Alan initially emerged as a digital health insurer. It swiftly evolved into a pioneering "prevention insurance" company. This innovative model integrates traditional health coverage with proactive care navigation and comprehensive wellbeing services. Artificial intelligence powers much of its platform. This approach aims to shift healthcare focus from reactive treatment to early intervention and prevention.
Alan’s integrated platform offers a unique healthcare experience. It combines diverse services under a single, user-friendly interface. Members access health coverage, care guidance, mental and physical wellbeing resources. AI-driven assistance further streamlines the experience. This design simplifies healthcare journeys for its growing user base.
The company demonstrates robust financial performance. In the first quarter of 2026, Alan surpassed €800 million in annual recurring revenue (ARR). This represents a significant 53% year-over-year growth. Alan maintains profitability in France, its largest and most established market. This financial strength provides a solid foundation for its ambitious expansion plans.
Alan serves a vast and diverse clientele. Over 1.1 million members now rely on its services. This includes individuals, more than 37,000 businesses, self-employed professionals, and retirees. The platform's adaptability caters to various segments of the healthcare market.
The fresh capital directly supports Alan's aggressive growth strategy. A primary focus is international expansion. Alan currently operates in France, Spain, Belgium, and Canada. The company intends to deepen its presence in these existing markets. It also plans to explore new countries, extending its reach globally.
Acquisitions form another key component of the strategic plan. Alan will pursue targeted acquisitions to bolster its capabilities and market share. This inorganic growth strategy complements its organic expansion efforts. These moves will consolidate its position as a leading health tech innovator.
Significant investment in artificial intelligence remains paramount. Alan aims to further develop its AI-native healthcare platform. This includes enhancing existing AI features and introducing new ones. The goal is to provide even more personalized, proactive, and efficient healthcare solutions. Investment in broader healthcare services and product development also continues. This ensures a continuously evolving and comprehensive offering.
Alan's long-term vision is clear: to establish prevention-focused insurance as the global preferred healthcare model. This ambition drives its product innovation and market penetration strategies. The company employs over 850 people, a dedicated team working towards this transformative goal.
The partnership with Prosus is highly strategic. Prosus brings deep expertise in international expansion and consumer products. This collaboration will help Alan scale its consumer offerings. It will also facilitate entry into large international markets where Prosus already holds a strong presence. Access to Prosus’ Large Commerce Model further accelerates Alan's AI-led product development.
Alan also fits into Prosus’ broader consumer ecosystem strategy. Its healthcare offerings strengthen Prosus’ life assistant strategy. This synergy benefits both entities, creating a more integrated consumer experience across various sectors.
Future initiatives include the planned launch of Alan Campus in January 2027. This digital health insurance offering targets students aged 18 to 28. It represents a strategic move to capture a crucial demographic early. This initiative aligns with Alan's prevention-first philosophy, promoting health awareness among young adults.
The company ensures robust operational integrity. It is regulated by the French Prudential Supervision and Resolution Authority. This oversight provides credibility and trust in its services.
Alan continues to redefine healthcare. Its focus on prevention, AI integration, and user-centric design sets a new industry standard. The recent funding round validates its approach. It also provides the necessary resources to accelerate its global mission. Alan's journey reflects a broader industry shift towards more proactive, technologically advanced healthcare solutions.